Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 27, 2018 - Elli Lilly announced the FDA approval of Emgality (galcanezumab-gnlm) for the preventive treatment of migraine in adults.
Download PDF
Return to publications
